In a surprising legal blow that has thrown a flagship foreign policy initiative into chaos, a Kenyan court has suspended a $2.5 billion “landmark” health aid deal with the United States, siding with citizens’ fears that the pact would hand over their most sensitive medical secrets.
The High Court’s interim ruling, issued just days after U.S. Secretary of State Marco Rubio lauded the agreement, bars the Kenyan government from implementing any part of the deal that facilitates “the transfer, sharing or dissemination of medical, epidemiological or sensitive personal health data.” The decision exposes a critical fault line in a new U.S. strategy to overhaul global health aid through direct government partnerships.
The Core Fear: America Wants Your Medical Records
The suspension follows an urgent case filed by the Consumer Federation of Kenya (Cofek), which argued the country risked “ceding strategic control of its health systems.” Public anxiety has centered on one explosive question: Could this deal allow U.S. officials to access personal medical records, including HIV status, TB treatment history, and vaccination data?
Despite reassurances from President William Ruto that Kenyan data law would prevail, the court found the concerns credible enough to freeze the entire agreement until a full hearing in February. The U.S. has not publicly addressed the data privacy allegations.
A New U.S. Strategy Hits a Legal Wall
The blocked deal is a cornerstone of the Trump administration’s new global health strategy, which bypasses traditional aid agencies to strike direct, multi-billion-dollar partnerships with national governments. Kenya’s pact, with the U.S. contributing $1.7 billion and Kenya $850 million, was meant to be a model.
Similar deals have since been signed with Rwanda, Lesotho, Liberia, and Uganda. But Kenya’s court ruling now poses a direct challenge to a key requirement of the U.S. approach: deep data sharing for disease surveillance and program management. Cofek’s warning about externally controlled “digital infrastructure (including cloud storage of raw data)” struck a chord with the judiciary.
A February Showdown and a Deal in Limbo
The case is set to return to court on February 12, setting up a high-stakes legal showdown that will determine the future of U.S.-Kenya health cooperation. For now, a deal celebrated as a diplomatic triumph is in legal limbo, its “landmark” status replaced by a single, powerful label: suspended.
The court’s message is clear: no amount of aid money is worth a nation’s sovereign control over its citizens’ private lives. The U.S. strategy has just encountered its first major roadblock, and it was built not on politics but on the fundamental right to data privacy.
